系统集成热稳定疫苗交付:融合无冷链设计,人工智能增强配方和气候适应性基础设施
Sonali Das1, Ayan Chatterjee2, Jhimli Manna1
1Advanced Technology Development Centre, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
Molecular pharmaceutics
|October 30, 2025
概括
热稳定疫苗消除了冷链的需要,改善了全球免疫公平. 对系统层面的整合和气候智能化交付策略需要进一步的研究.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 材料科学 材料科学 材料科学
- 公共卫生 公共卫生
背景情况:
- 传统疫苗需要严格的冷链储存 (2-8°C).
- 热稳定疫苗在环境温度 (高达40-45°C) 时具有有效性.
- 这使得公平和气候适应性免疫系统成为可能,特别是在资源较低的环境中.
研究的目的:
- 审查热稳定疫苗配方方面的进展.
- 确定系统层面集成的关键缺口,以便部署.
- 突出需要气候智能和可持续的疫苗供应.
主要方法:
- 关于助剂,纳米封装和稳定矩阵 (聚合物,MOF,脂质体) 的最新进展的审查.
- 对冷化和喷雾干燥等干燥技术的分析.
- 识别数字配方设计,人工智能,地理空间建模和生命周期工程中的研究缺口.
主要成果:
- 在材料创新和热耐受性生物物理稳定策略方面取得了重大进展.
- 现有的审查侧重于材料科学,仅限于系统集成.
- 在整合数字工具,智能物流,区块链和在具有挑战性的环境中部署政策方面存在差距.
结论:
- 热稳定的疫苗对于公平的免疫接种至关重要,特别是在气候脆弱的地区.
- 系统层面的整合,包括数字技术和智能物流,对于有效的部署至关重要.
- 解决这些差距将使气候智能和可持续的疫苗系统能够满足全球卫生需求.
更多相关视频
相关概念视频
01:51Vaccinations
51.2K
Overview
51.2K
01:22Development of Immunocompetence
781
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
781